Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.33 | 0.009 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.43 | 0.01 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |